Healthix Inc.

“Beginning in 2015, healthix, inc. Began using adp totalsource, a professional employer organization ("peo"). As a professional employer organization, totalsource provides professional employer services to healthix, inc. In the peo relationship totalsource and healthix, inc. Share certain responsibilities and allocate other employer responsibilities between each other. Healthix, inc. Remains an employer of the worksite employees and totalsource is a co-employer of healthix, inc.'s employees. Healthix, inc. Has: direction and control over employees as is necessary to conduct its business, discharge and fiduciary responsibility it may have, or comply with any applicable licensure, regulatory or statutory requirement of healthix, inc. Control over the day to day job duties of employees and over the job sites at which, or from which employees perform services responsibility over the professional and licensed activities of employees including ensuring that employees are supervised by licensed individuals as required by law and for determining whether an applicant or employee meets healthix, inc.'s hiring criteria and is qualified to safely and completely perform his or her job totalsource reserves a right of direction and control over employees as is necessary to fulfill its obligations and provide its services under an agreement between healthix, inc. And totalsource. Totalsource and healthix, inc. Have a right to hire, discipline, and terminate employees as to each one's employment relationship with employees. The peo was paid $95,463 during 2018 for services provided.”

“Membership: in order for an organization or individual to qualify to be a participant in the regional health information organization ("rhio") operated by the corporation ("participant"), he/she or it must enter into a rhio services, participation or similar agreement with the corporation (each, a "rhio services agreement"), the form of which has been approved by the board of directors of the corporation ("board"), to participate in a clinical information data exchange program with the corporation and to act as a data source and/or data user with respect to the corporation's data exchange. A participant's participation in the corporation will terminate if the rhio services agreement is terminated for any reason.”

“After the form is prepared by outside accountants, it will first be reviewed by the svp & cfo. If there are any suggested changes or modifications, he will communicate directly with the outside accountants. Once the svp & cfo is satisfied with the 990, he will pass it on to the ceo for his review. Once the ceo is satisfied with the 990, the next step is to pass it on to the chairman of the finance committee, who is a member of the executive committee and the board of directors, for his review. Once this individual is satisfied with the 990, it will be passed on to the full executive committee. This committee is a subset of the full healthix, inc. Board and is charged with making many key decisions affecting the company. It is this group of individuals that will authorize the filing of the 990. Once the executive committee is satisfied with the 990 and has authorized its filing, the svp & cfo will provide an electronic copy to the full board of directors prior to the extended due date of the return. The board will be informed that the executive committee has reviewed and approved the 990. If any board member has any questions or concerns they will be instructed to contact the svp & cfo, who will resolve their inquiries promptly.”

“All directors, officers, and key persons will, at least annually thereafter, file a written conflict of interest disclosure statement with healthix senior director of compliance. Healthix senior director of compliance will provide copies of all completed statements to the chair of the audit and compliance committee of the board for review. New director must file conflict of interest prior to being elected to become a healthix board member. For directors, the conflict of interest disclosure statement will specifically include, among other disclosable conflicts of interest, a statement identifying, to the best of the director's knowledge, any entity of which he or she is an officer, director, trustee, member, owner (either as a sole proprietor or a partner), or employee and with which healthix has a relationship, and any transaction in which healthix is a participant and in which the director might have a disclosable conflict of interest. All completed conflict of interest disclosure statements that raise an actual or potential conflict of interest, or that create the appearance of an actual or potential conflict of interest, will be forwarded by the chair of the audit and compliance committee to the audit and compliance committee for their consideration. The audit and compliance committee of the board will conduct a full review of all matters (e.g., contracts, transactions or arrangements) for which an actual or potential conflict of interest or the appearance of an actual or potential conflict of interest has been identified. In so doing, the audit and compliance committee of the board will: a. Consider all relevant facts and circumstances involved in the matter, and in particular, what is fair, reasonable and in the best interests of healthix; b. Exclude the affected individual(s) from being present at or participating in, or being counted in the quorum for, the deliberations or voting on the matter; c. Prohibit the affected individual(s) from any attempt to influence improperly the deliberations or voting on the matter; d. Permit the affected individual(s), upon request of the audit and compliance committee of the board, to present information concerning the matter at a meeting prior to commencement of deliberations or voting on the matter. E. Not permit any director to vote or be counted in determining the quorum for any vote, on any transaction between healthix and another corporation, firm, association or other entity in which the director is an officer or director or has a direct or indirect substantial financial interest. The audit and compliance committee of the board will make a final and binding determination as to whether a conflict of interest exists or may exist on any matter in which there is a disclosable conflict of interest, and what course healthix will take in connection with the matter. The audit and compliance committee of the board will contemporaneously document in writing in appropriate minutes of any meeting at which the matter is deliberated or voted upon all deliberations and determinations relating thereto, including, at a minimum: 1. The names and positions of persons who disclosed that they were related parties or otherwise were found to be related parties or to have a conflict of interest, a description of the nature of the relationship and/or substantial financial interest which gave rise to such disclosure or identification, and a description of the contract, transaction or arrangement at issue; 2. The names of the audit and compliance committee who were present during the taking of the action to determine whether a conflict of interests was present, and the basis for there being a quorum for the taking of such action without including any related parties or affected parties; 3. The steps taken by the audit and compliance committee members of the board to determine whether a conflict of interest was present; 4. The audit and compliance committee board member's decision as to whether a conflict”

“Ceo comp is set by an employment agreement. In a prior year (2015), the company re-engaged the services of an independent compensation consulting company which it had last used in 2012, the "hay group", which performed a formal market study and provided ranges for salaries and bonuses for certain executives and key employees of the company. Where an upward salary adjustment was needed to bring an employee to "market compensation", such an adjustment was made in q4 2015 to those affected employees. No downward salary adjustments were made resulting from this study. There was no need to engage the compensation consultant again in 2017 and 2018. The same process was used in 2018 as in 2017 for determining bonuses--no changes. Goals were set for all employees at the beginning of 2018, and their performance was measured against goals after 2018 concluded. Bonuses which were accrued at 12/31/17 (based on 2017 performance) were paid in 2018, and those which were accrued at 12/31/18 (based on 2018 performance) were paid out in 2019. The incentive compensation (i.e. Bonus) programs were approved by the executive committee for both 2017 & 2018, and were also distributed to all employees. The by-laws create a committee of the board with full powers of the board to review and approve the compensation of officers and other key employees. The committee, which is healthix's executive committee, consists of trustees who have no connection to healthix except as trustees and they have no conflicts as to matters they consider. The committee meets several times a year as needed and always reviews and determines officer and key employee compensation. For purposes of their review the committee considers the recommendations of the ceo for all persons other than the ceo. This process was last undertaken in 2018. The board's approval for the compensation of officers and other key employees is documented via email.”

“The organization makes its form 990 and form 1023 available for public inspection as required under section 6104 of the internal revenue code. It is posted on guidestar.org and other similar types of websites. In addition, the financial statements, conflict of interest policy, articles of incorporation and by-laws are also available upon written request or by calling the organization directly.”

“Additional ehrs. Healthix had identified 5 additional ehrs for ambulatory and ltpac providers which were capable of creating hub model interfaces, and committed to creating new hub interfaces with 3 of the 5 additional ehrs (with one site going live). Healthix was able to create hub model interfaces with all 5 of the identified ehrs (office practicum, reliable, welligent, athenahealth, and hha exchange), and 11 sites (3 welligent, 4 reliable, 2 office practicum, 1 hha exchange, and 1 athenahealth) have gone live. Phase 3: recruit at least 25 new participants who use the 5 additional ehrs. In the final phase, healthix was able to exceed the goal of recruiting 25 new participants who use the new ehrs, and recruited 36 sites (+44% of goal) during the year ending december 31, 2018, the company earned $42,185 in revenue in connection with this grant. Hgc #5 community consent capture project certain healthix participants use ehrs that cannot capture consent. Examples are physician practices using less widely installed ehrs, that do not take consent or cannot feed consent decisions to an hie. [amazing charts, a widely-installed hub model ehr, also does not take or transmit consent.] other participants want to take community consent, but their ehr cannot capture it. Examples include physician practices using ecw, the most widely installed ehr among physician practices in healthix. The staten island pps is an example of a participant that wants to encourage all of its pps partners to take community consent, based on success at two large ambulatory providers in the pps, but is hindered by inability of ecw to take community consent. In both cases, the provider needs a solution outside of the ehr to both check the patient's current consent status, take a new consent decision from the patient if appropriate, transmit it to healthix, and ensure a permanent record for audit. Healthix currently has a solution ("healthix hosted registration"), but nycig has developed a solution that is more efficient for the participant, and has implemented it successfully at four medical centers, a multi-site ambulatory network, and a nursing home, all of which actively use it. The electronic signature pads for other items requiring signature. Nycig has generously offered this software to healthix. Healthix is submitting this project to implement this solution, collaborate with nycig and share best practice between qes. Pcori cdrn program program description the patient-centered outcomes research institute (pcori) awarded a contract to weill cornell medical college for the new york city clinical data research network (cdrn) to: - build infrastructure to perform comparative effectiveness research - perform two observational studies on diabetes and cystic fibrosis - facilitate patient-centered research that can be linked to a national network - collaborate nationally with 10 other cdrns to develop best practices and support join studies healthix contribution the new york genome center functions as a trusted broker combining the clinical data from major health systems in nyc, several federally qualified health centers, as well as health plans. The healthix master patient index (mpi) is used to link patient records from across these facilities into a common data set for research. During the year ending december 31, 2018, the company earned $89,805 in revenue. Ppp background: the shin-ny roadmap includes ambitious but achievable physician participation goals. The high gap closure (hgc) pool was created to target funding to support attainment of these and other 2018 participation performance goals. Three qualified entities (qes) were eligible for this pool (healthix, nycig & healthlinkny) and submitted applications in response to nyec's request for proposals (rfps). After applications were scored, as outlined in the rfp, there are remaining funds of approximately $900,000. All hgc-eligible qes incur fees when connecting providers to their network. Some qes pass the”

“The organization's audit and compliance committee assumes responsibility for the oversight of the audit of its financial statements and selection of its independent auditors. The policy for selection and oversight of the independent auditors has not changed since last year.”